Why and how have drug discovery strategies in pharma changed? What are the new mindsets?

被引：53

作者：

Mignani, Serge ^{[1
]}

Huber, Scot ^{[2
]}

Tomas, Helena

Rodrigues, Joao ^{[3
]}

Majoral, Jean-Pierre ^{[4
,5
]}

机构：

[1] Univ Paris 05, CNRS UMR 860, Lab Chim & Biochim Pharmacol & Toxicol, PRES Sorbonne Paris Cite, 45 Rue St Peres, F-75006 Paris, France

[2] SCYNEXIS Inc, POB 12878, Res Triangle Pk, NC 27709 USA

[3] Univ Madeira, CQM, MMRG, Campus Univ Penteada, P-9000390 Funchal, Portugal

[4] CNRS, Lab Chim Coordinat, 205 Route Narbonne,BP 44099, F-31077 Toulouse 4, France

[5] Univ Toulouse, UPS, INPT, F-31077 Toulouse 4, France

来源：

DRUG DISCOVERY TODAY | 2016年 / 21卷 / 02期

关键词：

CHEMICAL BEAUTY; OPEN INNOVATION; 1ST-IN-CLASS; CHALLENGES; REVOLUTION; IMPACT; SPACE;

D O I：

10.1016/j.drudis.2015.09.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In the pharmaceutical industry the long-term challenge of drug innovation is the key phrase throughout R&D that refers to increasing the output of original drug candidate molecules. To increase R&D productivity, implementation of new and strategic R&D orientations to develop new approaches or systems to identify hits and leads efficiently has taken place and enabled all scientists working in the drug discovery domain to develop innovative medicines for the 21st century.

引用

页码：239 / 249

页数：11

共 50 条

[1] How Biologics Have Changed the Drug Discovery Landscape
Mcgonigle, Paul
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2025, 65 : 29 - 46
[2] Pharma may have no role in drug discovery
不详
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2002, 21 (04) : vii - vii
[3] Supreme Court Elections: How Much They Have Changed, Why They Changed, and What Difference It Makes
Baum, Lawrence
LAW AND SOCIAL INQUIRY-JOURNAL OF THE AMERICAN BAR FOUNDATION, 2017, 42 (03): : 900 - 923
[4] Why is big Pharma getting out of antibacterial drug discovery?
Projan, SJ
CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) : 427 - 430
[5] Predictive validity in drug discovery: what it is, why it matters and how to improve it
Jack W. Scannell
James Bosley
John A. Hickman
Gerard R. Dawson
Hubert Truebel
Guilherme S. Ferreira
Duncan Richards
J. Mark Treherne
Nature Reviews Drug Discovery, 2022, 21 : 915 - 931
[6] Predictive validity in drug discovery: what it is, why it matters and how to improve it
Scannell, Jack W.
Bosley, James
Hickman, John A.
Dawson, Gerard R.
Truebel, Hubert
Ferreira, Guilherme S.
Richards, Duncan
Treherne, J. Mark
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (12) : 915 - 931
[7] Back-up strategies in drug discovery: what, how and when?
Provins, Laurent
Jnoff, Eric
Genicot, Christophe
DRUG DISCOVERY TODAY, 2014, 19 (11) : 1808 - 1811
[8] How can pharma companies contribute to the ecosystem of drug discovery?
Tsukamoto, Issei
CANCER SCIENCE, 2024, 115 : 722 - 722
[9] Managing brand portfolios: How strategies have changed
Laforet, S
Saunders, J
JOURNAL OF ADVERTISING RESEARCH, 2005, 45 (03) : 314 - 327
[10] What I have changed my mind about and why
Yehuda, Rachel
Spiegel, David
Southwick, Steven
Davis, Lori L.
Neylan, Thomas C.
Krystal, John H.
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2016, 7

← 1 2 3 4 5 →